Chemours Maintains $475 Million-$525 Million Capex Guidance for 2018

SUGAR LAND--May 22, 2018--Researched by Industrial Info Resources (Sugar Land, Texas)--The Chemours Company (Chemours) (NYSE: CC) (Wilmington, Delaware) reported earlier this month that its first-quarter earnings were nearly double that of a year earlier, with its Fluoroproducts products, Titanium Technologies and Chemical Solutions segments all seeing an increase in sales. The company, which was spun off from DuPont in 2015, expects capital expenditures for 2018 to be within the range of $475 million to $525 million. Industrial Info is tracking more than $624 million in project activity by Chemours, including more than $544 million for capital projects.

Within this article: The Corpus Christi HFO-1234YF Hydrofluoroolefin Unit Addition. Additional companies: KBR Incorporated (NYSE:KBR)